🔗 Share this article

Treasury head Reeves has stated she is planning "targeted steps to address cost of living challenges" in the upcoming Budget.

During an interview with media outlets, she emphasized that reducing inflation is a joint responsibility of both the government and the central bank.

The UK's inflation rate is projected to be the highest among the Group of Seven industrialized countries this year and next.

Possible Energy Cost Measures

It is understood the government could take action to lower energy bills, for example by cutting the present 5% level of value-added tax charged on energy.

Another approach is to reduce some of the regulatory levies presently added to bills.

Fiscal Constraints and Analyst Expectations

The administration will obtain the next draft from the independent fiscal watchdog, the OBR, on Monday, which will clarify how much scope there is for these actions.

The view from most economists is that Reeves will have to declare higher taxes or spending cuts in order to meet her voluntary debt limits.

Previously on Thursday, analysis indicated there was a twenty-two billion pound gap for the chancellor to address, which is at the lower end of expectations.

"There's a collective task between the Bank of England and the administration to further reduce some of the drivers of inflation," the Chancellor told the BBC in Washington, at the yearly gatherings of the IMF and World Bank.

Revenue Pledges and Global Concerns

While much of the focus has been on probable tax rises, the Treasury chief said the latest data from the OBR had not altered her vow to election pledges not to raise rates on earnings tax, VAT or social security contributions.

She blamed an "unpredictable global environment" with increasing international and commercial tensions for the fiscal revenue measures, probably to be targeted on those "wealthiest."

International Economic Tensions

Addressing concerns about the UK's economic relations with the Asian nation she said: "Our national security invariably are paramount."

Recent announcement by Chinese authorities to tighten export controls on rare earths and other materials that are essential for high-technology production led US President Donald Trump to threaten an extra 100% import tax on goods from the Asian country, raising the prospect of an all-out commercial conflict between the two largest economies.

The US Treasury Secretary called the Chinese decision "commercial pressure" and "a global supply chain power grab."

Questioned on accepting the US offer to participate in its conflict with the Asian nation, Reeves said she was "deeply worried" by China's measures and encouraged the Chinese government "not to put up barriers and limit trade."

She said the action was "damaging for the global economy and generates additional obstacles."

"I believe there are areas where we need to address China, but there are also significant prospects to sell into Chinese markets, including banking sector and other sectors of the economic system. We've got to achieve that equilibrium appropriate."

The Treasury chief also confirmed she was cooperating with international partners "on our own critical minerals approach, so that we are reduced dependence."

NHS Medicine Costs and Funding

The Chancellor also recognized that the cost the NHS pays for medicines could go up as a result of ongoing discussions with the US government and its drugs companies, in return for reduced taxes and capital.

A number of the biggest global pharmaceutical manufacturers have said in recent statements that they are either delaying or scrapping operations in the United Kingdom, with some attributing the modest returns they are getting.

Recently, the Science Minister said the price the NHS spends on drugs would must increase to halt businesses and drug research funding departing from the UK.

The Chancellor informed media: "It has been observed because of the pricing regime, that medical research, innovative medicines have not been offered in the United Kingdom in the manner that they are in other continental states."

"Our aim is to guarantee that individuals receiving treatment from the NHS are able to receive the finest critical medicines in the world. And so we are looking at all of that, and... looking to obtain more capital into the UK."